Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$110.31 -1.85 (-1.65%)
As of: Nov 12, 2026 · 11:45 AM EST

Rhythm Pharmaceuticals (RYTM) Cost of Revenue (2021 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Cost of Revenue of $12.17 million for Q3 2026, up 121.2% from $5.5 million a year earlier and up 36.2% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Cost of Revenue (2021 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Rhythm Pharmaceuticals' Cost of Revenue came in at $33.06 million, up 78.9% year-over-year; for FY2025, it came in at $19.49 million, up 45.8% from FY2024.

  • Cost of Revenue has increased for four consecutive years, with a four-year compound annual growth rate of 138.8% (FY2021 to FY2025).
  • By year, Cost of Revenue came in at $13.37 million in FY2024 (+43.7%), $9.3 million in FY2023 (+336.1%), $2.13 million in FY2022 (+256.1%) and $599,000 in FY2021.
  • The Q3 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2021.
  • Year over year, Cost of Revenue has now increased in each of the last 18 quarters, with growth averaging 60.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Cost of Revenue ran from 17.1% in Q4 2024 to 517.8% in Q1 2023.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $8.93 million (Q2 2026), $7.16 million (Q1 2026) and $4.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn 12.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.17 Mn
Jun 30, 2026 8.93 Mn
Mar 31, 2026 7.16 Mn
Dec 31, 2025 4.80 Mn
Sep 30, 2025 5.50 Mn
Jun 30, 2025 5.54 Mn
Mar 31, 2025 3.65 Mn
Dec 31, 2024 3.79 Mn
Sep 30, 2024 3.83 Mn
Jun 30, 2024 2.95 Mn
Mar 31, 2024 2.81 Mn
Dec 31, 2023 3.23 Mn
Sep 30, 2023 2.41 Mn
Jun 30, 2023 2.24 Mn
Mar 31, 2023 1.42 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 497,000.00
Jun 30, 2022 378,000.00
Mar 31, 2022 230,000.00
Dec 31, 2021 236,000.00
API Access

Rhythm Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RYTM&period=max&api_key=YOUR_API_KEY